Nutrien Financials
Nutrien (NTR) reported $26.9B in revenue for fiscal year 2025, up 3.5% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2025 shows a cash-and-profit rebound built on high earnings sensitivity to modest sales changes and low borrowing.
From FY2024 to FY2025, revenue rose only3.5% , yet net income more than tripled to$2.3B . At the same time, free cash flow rose by40.7% to$2.1B , showing small sales moves are amplified into much larger swings in profit and cash.
Across FY2023-FY2025, operating cash flow stayed between
The balance sheet is funded more by equity and operating liabilities than by long-term debt: cash was only
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Nutrien's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Not available for Nutrien, and counted as zero in the overall score.
Nutrien's revenue grew a modest 3.5% year-over-year to $26.9B. This slow but positive growth earns a score of 20/100.
Nutrien carries a low D/E ratio of 0.04, meaning only $0.04 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 85/100, indicating a strong balance sheet with room for future borrowing.
Nutrien's current ratio of 1.34 indicates adequate short-term liquidity, earning a score of 35/100. The company can meet its near-term obligations, though with limited headroom.
Nutrien has a free cash flow margin of 7.9%, earning a moderate score of 59/100. The company generates positive cash flow after capital investments, but with room for improvement.
Not available for Nutrien, and counted as zero in the overall score.
Nutrien passes 7 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 2 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Nutrien generates $1.74 in operating cash flow ($4.0B OCF vs $2.3B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Nutrien generated $26.9B in revenue in fiscal year 2025. This represents an increase of 3.5% from the prior year.
Nutrien reported $2.3B in net income in fiscal year 2025. This represents an increase of 228.1% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Nutrien generated $2.1B in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 40.7% from the prior year.
Nutrien held $701.0M in cash against $937.0M in long-term debt as of fiscal year 2025, with $11.0B of liabilities due within a year.
Not reported for fiscal year 2025.
Margins & Returns
Nutrien's net profit margin was 8.5% in fiscal year 2025, showing the share of revenue converted to profit. This is up 5.8 percentage points from the prior year.
Nutrien's ROE was 9.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 6.2 percentage points from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Capital Allocation
Nutrien spent $560.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 194.7% from the prior year.
Nutrien invested $1.9B in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 7.1% from the prior year.
Not reported for fiscal year 2025.
NTR Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $26.9B+3.5% | $26.0B-10.6% | $29.1B-23.3% | $37.9B+36.7% | $27.7B+32.5% | $20.9B+4.1% | $20.1B+2.3% | $19.6B+331.8% | $4.5B |
| Income Tax | $752.0M+72.5% | $436.0M-34.9% | $670.0M-73.8% | $2.6B+158.7% | $989.0M+1384.4% | -$77.0M-124.4% | $316.0M+439.8% | -$93.0M+49.2% | -$183.0M |
| Net Income | $2.3B+228.1% | $700.0M-45.4% | $1.3B-83.3% | $7.7B+141.8% | $3.2B+592.6% | $459.0M-53.7% | $992.0M-72.2% | $3.6B+992.7% | $327.0M |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | $1.70+3500.0% | -$0.05-127.8% | $0.18 |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, Interest Expense.
NTR Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $52.3B+0.9% | $51.8B-1.7% | $52.7B-3.4% | $54.6B+9.3% | $50.0B+5.9% | $47.2B+0.8% | $46.8B+2.9% | $45.5B+167.7% | $17.0B |
| Current Assets | $14.7B+6.9% | $13.8B-2.7% | $14.2B-13.3% | $16.3B+18.0% | $13.8B+20.7% | $11.5B+7.5% | $10.7B-8.5% | $11.7B+250.9% | $3.3B |
| Cash & Equivalents | $701.0M-17.8% | $853.0M-9.4% | $941.0M+4.4% | $901.0M+80.6% | $499.0M-65.7% | $1.5B+116.7% | $671.0M-71.0% | $2.3B+1894.8% | $116.0M |
| Inventory | $7.0B+13.5% | $6.1B-3.0% | $6.3B-17.0% | $7.6B+20.6% | $6.3B+28.4% | $4.9B-0.9% | $5.0B+1.2% | $4.9B+524.0% | $788.0M |
| Accounts Receivable | $5.7B+5.3% | $5.4B-0.1% | $5.4B-12.9% | $6.2B+15.4% | $5.4B+48.0% | $3.6B+2.4% | $3.5B+6.0% | $3.3B+583.4% | $489.0M |
| Goodwill | $12.1B+0.8% | $12.0B-0.6% | $12.1B-2.1% | $12.4B+1.2% | $12.2B+0.2% | $12.2B+1.8% | $12.0B+4.9% | $11.4B+11684.5% | $97.0M |
| Total Liabilities | $26.9B-1.7% | $27.4B-0.5% | $27.5B-4.1% | $28.7B+9.4% | $26.3B+5.9% | $24.8B+3.6% | $23.9B+13.5% | $21.1B+142.4% | $8.7B |
| Current Liabilities | $11.0B-8.3% | $12.0B-0.6% | $12.1B-15.1% | $14.3B+14.8% | $12.4B+46.7% | $8.5B-7.1% | $9.1B+9.5% | $8.3B+420.3% | $1.6B |
| Long-Term Debt | $937.0M-6.2% | $999.0M0.0% | $999.0M+11.1% | $899.0M-3.7% | $934.0M+4.8% | $891.0M+3.7% | $859.0M+7058.3% | $12.0M-99.7% | $3.8B |
| Total Equity | $25.4B+3.8% | $24.4B-3.0% | $25.2B-2.6% | $25.9B+9.1% | $23.7B+5.8% | $22.4B-2.2% | $22.9B-6.2% | $24.4B+194.2% | $8.3B |
| Retained Earnings | $12.1B+8.7% | $11.1B-3.7% | $11.5B-3.3% | $11.9B+45.6% | $8.2B+24.0% | $6.6B-7.0% | $7.1B-8.3% | $7.7B+24.1% | $6.2B |
NTR Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.0B+13.4% | $3.5B-30.2% | $5.1B-37.5% | $8.1B+108.7% | $3.9B+16.9% | $3.3B-9.3% | $3.7B+78.6% | $2.1B+67.5% | $1.2B |
| Capital Expenditures | $1.9B-7.1% | $2.0B-16.1% | $2.4B+7.2% | $2.3B+26.8% | $1.8B+24.9% | $1.4B-17.7% | $1.7B+23.0% | $1.4B+115.8% | $651.0M |
| Free Cash Flow | $2.1B+40.7% | $1.5B-43.0% | $2.7B-54.7% | $5.9B+177.7% | $2.1B+11.0% | $1.9B-1.9% | $1.9B+199.4% | $647.0M+12.7% | $574.0M |
| Investing Cash Flow | -$1.4B+35.7% | -$2.1B+27.9% | -$3.0B-2.0% | -$2.9B-60.5% | -$1.8B-50.1% | -$1.2B+57.0% | -$2.8B-172.0% | $3.9B+696.2% | -$652.0M |
| Financing Cash Flow | -$2.8B-93.9% | -$1.5B+29.5% | -$2.1B+56.4% | -$4.7B-57.5% | -$3.0B-124.3% | -$1.3B+46.0% | -$2.5B+33.1% | -$3.7B-657.7% | -$489.0M |
| Dividends Paid | $1.1B+0.1% | $1.1B+2.7% | $1.0B+0.1% | $1.0B-1.3% | $1.0B+1.5% | $1.0B+0.8% | $1.0B+7.4% | $952.0M+188.5% | $330.0M |
| Share Buybacks | $560.0M+194.7% | $190.0M-81.0% | $1.0B-77.8% | $4.5B+306.9% | $1.1B+590.6% | $160.0M-91.5% | $1.9B+1.4% | $1.9B | N/A |
NTR Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 8.5%+5.8pp | 2.7%-1.7pp | 4.4%-15.9pp | 20.3%+8.8pp | 11.5%+9.3pp | 2.2%-2.7pp | 4.9%-13.3pp | 18.2%+11.0pp | 7.2% |
| Return on Equity | 9.1%+6.2pp | 2.9%-2.2pp | 5.1%-24.6pp | 29.7%+16.3pp | 13.4%+11.4pp | 2.1%-2.3pp | 4.3%-10.3pp | 14.6%+10.7pp | 3.9% |
| Return on Assets | 4.4%+3.0pp | 1.4%-1.1pp | 2.4%-11.7pp | 14.1%+7.7pp | 6.4%+5.4pp | 1.0%-1.1pp | 2.1%-5.7pp | 7.8%+5.9pp | 1.9% |
| Current Ratio | 1.34+0.2x | 1.150.0x | 1.170.0x | 1.140.0x | 1.11-0.2x | 1.35+0.2x | 1.17-0.2x | 1.40-0.7x | 2.07 |
| Debt-to-Equity | 0.040.0x | 0.040.0x | 0.040.0x | 0.030.0x | 0.040.0x | 0.040.0x | 0.040.0x | 0.00-0.5x | 0.45 |
| FCF Margin | 7.9%+2.1pp | 5.8%-3.3pp | 9.1%-6.3pp | 15.5%+7.8pp | 7.6%-1.5pp | 9.1%-0.6pp | 9.6%+6.3pp | 3.3%-9.3pp | 12.6% |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin.
Similar Companies
Where Nutrien Ranks
Frequently Asked Questions
What is Nutrien's annual revenue?
Nutrien (NTR) reported $26.9B in total revenue for fiscal year 2025. This represents a 3.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Nutrien's revenue growing?
Nutrien (NTR) revenue grew by 3.5% year-over-year, from $26.0B to $26.9B in fiscal year 2025.
Is Nutrien profitable?
Yes, Nutrien (NTR) reported a net income of $2.3B in fiscal year 2025, with a net profit margin of 8.5%.
How much debt does Nutrien have?
As of fiscal year 2025, Nutrien (NTR) had $701.0M in cash and equivalents against $937.0M in long-term debt.
What is Nutrien's net profit margin?
Nutrien (NTR) had a net profit margin of 8.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Nutrien's return on equity (ROE)?
Nutrien (NTR) has a return on equity of 9.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Nutrien's free cash flow?
Nutrien (NTR) generated $2.1B in free cash flow during fiscal year 2025. This represents a 40.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Nutrien's operating cash flow?
Nutrien (NTR) generated $4.0B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Nutrien's total assets?
Nutrien (NTR) had $52.3B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Nutrien's capital expenditures?
Nutrien (NTR) invested $1.9B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Nutrien's current ratio?
Nutrien (NTR) had a current ratio of 1.34 as of fiscal year 2025, which is considered adequate.
What is Nutrien's debt-to-equity ratio?
Nutrien (NTR) had a debt-to-equity ratio of 0.04 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Nutrien's return on assets (ROA)?
Nutrien (NTR) had a return on assets of 4.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Nutrien's Piotroski F-Score?
Nutrien (NTR) has a Piotroski F-Score of 7 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Nutrien's earnings high quality?
Nutrien (NTR) has an earnings quality ratio of 1.74x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Nutrien?
Nutrien (NTR) scores 33 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.